Analystreport

Alexion Pharmaceuticals (NASDAQ: ALXN) had its "buy" rating re-affirmed by analysts at Raymond James.

Alexion Pharmaceuticals, Inc  (ALXN) 
Last alexion pharmaceuticals, inc earnings: 1/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.alexion.com/investor-relations